| Literature DB >> 26259804 |
Jeffrey T Bagdanoff1, Rama Jain2, Wooseok Han2, Shejin Zhu2, Ann-Marie Madiera2, Patrick S Lee2, Xiaolei Ma2, Daniel Poon2.
Abstract
A series of structure based drug design hypotheses and focused screening efforts led to the identification of tetrahydropyrrolo-diazepenones with striking potency against ERK2 kinase. The role of fluorination in mitigating microsomal clearance was systematically explored. Ultimately, it was found that fluorination of a cyclopentanol substructure provided significant improvement in both potency and human metabolic stability.Entities:
Keywords: ATP binding cleft; ERK2 kinase; Extraction ratio; Lower-hinge lysine; Structure based drug design
Mesh：
Substances：
Year: 2015 PMID： 26259804 DOI： 10.1016/j.bmcl.2015.07.091
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN： 0960-894X Impact factor: 2.823